Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
netFormulary
Home
Treatment Use
Class
Chapters
News
Reports
Contact
SEARCH
Searching for :
Prednisolone
Open monograph to display formulary status.
Formulary items found
Status
Description
Section
Amber SPA
Methylprednisolone
(Tablets)
Endocrine system, Glucocorticoid therapy, 06.03.02
GREEN
Methylprednisolone Acetate
(Depo injection)
Endocrine system, Glucocorticoid therapy, 06.03.02
GREEN
Methylprednisolone Acetate Depo-Medrone
®
(Depo Injection)
Musculoskeletal and joint diseases, Local corticosteroids injections, 10.01.02.02
RED
Methylprednisolone sodium succinate Solu-Medrone
®
Endocrine system, Glucocorticoid therapy, 06.03.02
GREEN
Prednisolone
(Tablets)
Endocrine system, Glucocorticoid therapy, 06.03.02
GREEN
Prednisolone Soluble Tablets 5mg
Endocrine system, Glucocorticoid therapy, 06.03.02
Amber SPA
Prednisolone
Gastro-intestinal system, Corticosteroids, 01.05.02
GREEN
Prednisolone
Malignant disease and immunosuppression, Corticosteroids and other immunosuppressants, 08.02.02
RED
Prednisolone
(10mg in 1ml Oral Solution)
Endocrine system, Glucocorticoid therapy, 06.03.02
Amber SPA
Prednisolone
(Eye drops)
Eye, Corticosteroids, 11.04.01
GREEN
Prednisolone 0.5% Predsol
®
Ear, nose and oropharynx, Anti-inflammatory preparations, 12.01.01
Amber SPA
Prednisolone preservative free eye drops
(Sigle use (Minims))
Eye, Corticosteroids, 11.04.01
RED
Rituximab Truxima
®
Nutrition and blood, Drugs used in hypoplastic, haemolytic, and renal anaemias and in sickle cell disease, 09.01.03
Non Formulary items found
Status
Description
Section
Methylprednisolone Acetate Depo-Medrone
®
with Lidocaine
Musculoskeletal and joint diseases, Local corticosteroids injections, 10.01.02.02
DNP
Prednisolone
(Enteric Coated)
Malignant disease and immunosuppression, Corticosteroids and other immunosuppressants, 08.02.02
Prednisolone 0.5% with Neomycin 0.5% Predsol-N
®
Ear, nose and oropharynx, Anti-inflammatory preparations, 12.01.01
Prednisolone 0.5% with Neomycin 0.5% Predsol-N
®
Eye, Corticosteroids, 11.04.01
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local
BNF
Section
Cinchocaine
Cinchocaine With Prednisolone
Gastro-Intestinal System, Anaesthetics, Local, Amides
Rectal And Anal Disorders, Haemorrhoids
Cinchocaine
Cinchocaine With Prednisolone
Gastro-Intestinal System, Corticosteroids
Rectal And Anal Disorders, Haemorrhoids
Methylprednisolone
Methylprednisolone
Endocrine System, Corticosteroids
Corticosteroid Responsive Conditions
Methylprednisolone
Methylprednisolone
Gastro-Intestinal System, Corticosteroids
Chronic Bowel Disorders, Inflammatory Bowel Disease
Methylprednisolone
Methylprednisolone
Musculoskeletal System, Corticosteroids
Soft Tissue And Joint Disorders, Local Inflammation Of Joints And Soft Tissue
Methylprednisolone
Methylprednisolone With Lidocaine
Musculoskeletal System, Anaesthetics, Local
Soft Tissue And Joint Disorders, Local Inflammation Of Joints And Soft Tissue
Methylprednisolone
Methylprednisolone With Lidocaine
Musculoskeletal System, Corticosteroids
Soft Tissue And Joint Disorders, Local Inflammation Of Joints And Soft Tissue
Prednisolone
Prednisolone
Ear, Corticosteroids
Otitis Externa
Prednisolone
Prednisolone
Endocrine System, Corticosteroids
Corticosteroid Responsive Conditions
Prednisolone
Prednisolone
Eye, Corticosteroids
Otitis Externa
Prednisolone
Prednisolone
Gastro-Intestinal System, Corticosteroids
Chronic Bowel Disorders, Inflammatory Bowel Disease
Prednisolone
Prednisolone
Musculoskeletal System, Corticosteroids
Soft Tissue And Joint Disorders, Local Inflammation Of Joints And Soft Tissue
Links found
MHRA Drug Safety Update (Dec 2017): Radium-223 dichloride (Xofigo▼): do not use in combination with abiraterone and prednisone/prednisolone, following clinical trial signal of increased risk of death and fractures